Organic Equinox Elixir 50ml
Organic Equinox Elixir is the perfect seasonal revival for your body and senses at Equinox and Solstice. This tincture has been created with extracts of dandelion, burdock, artichoke, nettle and cleavers, grown, produced and bottled on an organic farm in England. 100% active ingredients with no artificial fillers and no nasties.
Out of stock
Viridian’s 100% Organic Equinox Elixir is the perfect seasonal revival for your body and senses at Equinox and Solstice.
This tincture has been created by steeping organic extracts of dandelion, burdock, artichoke, nettle, cleavers, and acacia honey in organic alcohol. It may be used to gently encourage the removal of waste compounds so that your body is better able to carry out normal processes efficiently and may also improve all-round energy and vitality.
All of Viridian’s tinctures are grown, produced and bottled on an organic farm in England. The plants are all grown from hand-sown seeds in spring, and then hand-picked at the end of summer as part of a slow and delicate process that preserves the integrity of each plant.
Our range of tinctures have all been certified organic by the Soil Association – better for the planet, better for you. This botanical food supplement is best taken by mixing into cold drinks or adding to hot water.
Contains 100% active ingredients formulated by expert nutritionists with no artificial fillers and no nasties. Sourced according to Viridian’s strict ethical criteria including no animal testing, GMO or palm oil.
Just to make you aware we are currently updating our packaging so your supplement may look a little different.Please don’t worry, it’s the same goodness inside.
|Organic Acacia Honey||20%|
|Organic Dandelion Extract||16%|
|Organic Burdock Extract||16%|
|Organic Artichoke Extract||16%|
|Organic Nettle Extract||16%|
|Organic Cleavers Extract||16%|
DISCLAIMER: Product information correct at the time of publication. Viridian regularly updates product formulations in order to improve product efficacy, which can result in 2 or more concurrent formulation variations in our current stock.